Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RWDC Industries is an industrial biotechnology and biomaterials company developing and manufacturing polyhydroxyalkanoate (PHA)-based materials as replacements for conventional petroleum-derived plastics. Its flagship product family, Solon, is a bio-based and fully biodegradable PHA resin designed for applications including food service items, food packaging, consumer goods packaging, non-wovens, textiles, and paper and board barrier coatings. The company positions itself as more than a resin supplier, offering proprietary PHA production, resin formulation, and application-development support to help customers adopt drop-in sustainable materials on existing manufacturing lines. RWDC operates from Singapore and Athens, Georgia, and has pursued partnerships to scale commercialization and manufacturing of PHA solutions globally. Although sometimes described as a biotech company, its primary business is materials science and sustainable packaging rather than therapeutics or healthcare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RWDC Industries.